Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Oncopeptides AB

Closing information (x1000 DKK)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 24,381 Less Arrow 5,583 More Arrow 86,016
Financial expenses 3,886 Less Arrow 590 More Arrow 689
Earnings before taxes -166,876 Less Arrow -225,649 Less Arrow -1,033,524
EBITDA -162,819 Less Arrow -221,966 Less Arrow -1,017,655
Total assets 160,112 More Arrow 257,486 More Arrow 319,485
Current assets 136,283 More Arrow 243,260 More Arrow 299,849
Current liabilities 30,180 More Arrow 55,582 More Arrow 163,783
Equity capital 38,138 More Arrow 196,656 Less Arrow 153,329
- share capital 7,060 Less Arrow 7,002 Less Arrow 6,083
Employees (average) 52 More Arrow 57 More Arrow 229

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 23.8% More Arrow 76.4% Less Arrow 48.0%
Turnover per employee 469 Less Arrow 98 More Arrow 376
Profit as a percentage of turnover -684.5% Less Arrow -4041.7% More Arrow -1201.5%
Return on assets (ROA) -101.8% More Arrow -87.4% Less Arrow -323.3%
Current ratio 451.6% Less Arrow 437.7% Less Arrow 183.1%
Return on equity (ROE) -437.6% More Arrow -114.7% Less Arrow -674.1%
Change turnover 18,769 Less Arrow -73,466 More Arrow 86,016
Change turnover % 334% Less Arrow -93%
Chg. No. of employees -5 Less Arrow -172 More Arrow 47
Chg. No. of employees % -9% Less Arrow -75% More Arrow 26%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.